Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients

被引：9
|
作者：
Bloomfield, Marketa [1 ,2 ,3 ,4 ]
Parackova, Zuzana [1 ,2 ]
Hanzlikova, Jana [5 ,6 ]
Lastovicka, Jan [1 ,2 ]
Sediva, Anna [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Dept Immunol, V Uvalu 84, Prague 15006, Czech Republic
[2] Univ Hosp Motol, V Uvalu 84, Prague 15006, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague, Czech Republic
[4] Thomayer Univ Hosp, Prague, Czech Republic
[5] Charles Univ Prague, Dept Immunol & Allergol, Fac Med, Plzen, Czech Republic
[6] Charles Univ Prague, Fac Hosp Pilsen, Plzen, Czech Republic
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / 02期
关键词：
D O I：
10.1007/s10875-021-01163-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：266 / 269
页数：4
相关论文
共 50 条
  • [21] IMMUNOGENICITY AND SAFETY OF INACTIVATED AND MRNA COVID-19 VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    So, H.
    Li, T. K.
    Chan, V.
    Tam, L. S.
    Chan, P. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 675 - 675
  • [22] Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus
    So, Ho
    Li, Tena
    Chan, Vivien
    Lai-Shan Tam
    Chan, Paul K. S.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [23] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers
    Rojkovich, Bernadette
    Nemeth, Dora
    Torok, Eszter
    Szabo, Bernadette
    Pinter, Agnes
    Juhasz, Istvan
    Weidl, Marton
    Lanyi, Eva
    Pavel-Szecsko, Judit
    Lazar, Imre
    Perduk, Andras
    Reiter, Jozsef
    Nagy, Gyorgy
    Nagy, Erzsebet
    Geher, Pal
    ORVOSI HETILAP, 2021, 162 (39) : 1551 - 1557
  • [24] mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase
    Koo, Grace
    Anvari, Sara
    Friedman, Debra L.
    Zarnegar-Lumley, Sara
    Szafron, Vibha
    Kahwash, Basil M.
    Onasch, K. Michelle
    Hall, Laura
    Phillips, Elizabeth J.
    Stone, Cosby A., Jr.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 322 - 325
  • [25] COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
    Bhella, Sita
    Wilkin, Allison M.
    Hueniken, Katrina
    Vijenthira, Abi
    Sebag, Michael
    Wang, Peng
    Hicks, Lisa K.
    Hay, Annette E.
    Assouline, Sarit
    Fraser, Graeme
    Balitsky, Amaris
    Mangel, Joy
    Owen, Carolyn
    Reiman, Anthony
    Sehn, Laurie
    Sutherland, Heather
    Zhang, Tinghua
    Arnold, Corey
    Leite, Tamara
    Mccarthy, Erinn
    Cooper, Curtis
    Langlois, Marc-Andre
    Buchan, C. Arianne
    VACCINE, 2024, 42 (24)
  • [26] Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
    van Leeuwen, Leanne P. M.
    GeurtsvanKessel, Corine H.
    Ellerbroek, Pauline M.
    de Bree, Godelieve J.
    Potjewijd, Judith
    Rutgers, Abraham
    Jolink, Hetty
    van de Veerdonk, Frank
    van Gorp, Eric C. M.
    de Wilt, Faye
    Bogers, Susanne
    Gommers, Lennert
    Geers, Daryl
    Bruns, Anke H. W.
    Leavis, Helen L.
    van Haga, Jelle W.
    Lemkes, Bregtje A.
    van der Veen, Annelou
    de Kruijf-Bazen, S. F. J.
    van Paassen, Pieter
    de Leeuw, Karina
    van de Ven, Annick A. J. M.
    Verbeek-Menken, Petra H.
    van Wengen, Annelies
    Arend, Sandra M.
    Ruten-Budde, Anja J.
    van der Ent, Marianne W.
    van Hagen, P. Martin
    Sanders, Rogier W.
    Grobben, Marloes
    van der Straten, Karlijn
    Burger, Judith A.
    Poniman, Meliawati
    Nierkens, Stefan
    van Gils, Marit J.
    de Vries, Rory D.
    Dalm, Virgil A. S. H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 1949 - 1957
  • [27] Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
    Ligumsky, Hagai
    Safadi, Esraa
    Etan, Tal
    Vaknin, Noam
    Waller, Manuel
    Croll, Assaf
    Nikolaevski-Berlin, Alla
    Greenberg, Inbal
    Halperin, Tami
    Wasserman, Asaf
    Galazan, Lior
    Arber, Nadir
    Wolf, Ido
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 203 - 209
  • [28] Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines
    Alesci, Alessio
    Gitto, Marco
    Nska, Magdalena Kota
    Lo Cascio, Patrizia
    Miller, Anthea
    Nicosia, Noemi
    Fumia, Angelo
    Pergolizzi, Simona
    HUMAN IMMUNOLOGY, 2022, 83 (11) : 755 - 767
  • [29] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
    Levy, Itzchak
    Wieder-Finesod, Anat
    Litchevsky, Vladyslav
    Biber, Asaf
    Indenbaum, Victoria
    Olmer, Liraz
    Huppert, Amit
    Mor, Orna
    Goldstein, May
    Levin, Einav Gal
    Hod, Tammy
    Cohen, Carmit
    Lustig, Yaniv
    Rahav, Galia
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1851 - 1855
  • [30] Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
    Tangsathapornpong, Auchara
    Nanthapisal, Sira
    Pontan, Kanassanan
    Bunjoungmanee, Pornumpa
    Neamkul, Yamonbhorn
    Boonyarangkul, Arthit
    Wanpen, Supattra
    Fukpho, Waraphon
    Jitpokasem, Sumana
    Tharabenjasin, Phuntila
    Jaru-Ampornpan, Peera
    VACCINES, 2023, 11 (03)
12345